LDL particle size in relation to insulin, proinsulin, and insulin sensitivity: The Insulin Resistance Atherosclerosis Study

Diabetes Care

Volumn 22, Issue 10, 1999, Pages 1688-1693

  Festa, Andreas ^a   D'Agostino Jr , Ralph ^b   Mykkänen, Leena ^a   Tracy, Russell P ^c   Hales, C Nick ^e   Howard, Barbara V ^d   Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d Medlantic Research Institute   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; PROINSULIN; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CLINICAL TRIAL; ETHNIC GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARTICLE SIZE; PROTEIN LOCALIZATION;

ARTERIOSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; ENGLAND; ETHNIC GROUPS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, LDL; MALE; MULTIVARIATE ANALYSIS; PROINSULIN; REGRESSION ANALYSIS; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES; UNITED STATES;

EID: 0032836935     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.10.1688     Document Type: Article

References (51)

1. Shen MMS, Krauss RM, Lindgren FT, Forte TM: Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 22:236-244, 1981
2. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
3. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921, 1988
4. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12:187-195, 1992
5. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Circulation 95:69-75, 1997
6. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV: Low density lipoprotein size and subclass pattern in a biethnic population. Arterioscler Thromb 13:1623-1630, 1993
7. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EJ, Krauss RM: LDL subclass pattern and the insulin resistance syndrome in women. Circulation 88:381-387, 1993
8. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM: Insulin resistance and hyperinsulinaemia in individuals with small dense low density lipoprotein particles. J Clin Invest 92:141-146, 1993
9. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R: Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinaemia and atherosclerosis. Diabetes 39:1527-1533, 1990
10. Haffner SM, Mykkänen L, Stern MP, Paidi M, Howard BV: Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17:1164-1171, 1994
11. Haffner SM, Mykkänen L, Robbins D, Valdez R, Miettinen H, Howard BV, Stern MP, Bowsher R: A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 38:1328-1336, 1995
12. Tchernof A, Lamarche B, Prud'homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Després JP: The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19:629-637, 1996
13. Stewart MW, Laker MF, Dyer RG, Game F, Mitcheson J, Winocour PH, Alberti KGMM: Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb 13:1046-1052, 1993
14. Tan KCB, Cooper MB, Ling KLE, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ: Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 113:273-287, 1995
15. Mykkänen L, Haffner SM, Rainwater DL, Karhapää P, Miettinen H, Laakso M: Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol 17:1447-1453, 1997
16. Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, Welty TK, Lee ET, Krauss RM, Howard BV: Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians: the Strong Heart Study. Arterioscler Thromb Vasc Biol 17:2713-2720, 1997
17. Lahdenperä S, Sane T, Vuorinen-Markkola H, Knudsen P, Taskinen MR: LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis 113:227-236, 1995
18. Slyper AH, Zvereva S, Schectman G, Hoffmann RG, Mueller RA, Walker JA: Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism 46:1275-1280, 1997
19. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet i:293-295, 1989
20. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH: Biosynthetic human proinsulin: review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 15:666-692, 1992
21. Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B, Galloway J, Olefsky JM: The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 33:762-770, 1984
22. Spradlin CT, Galloway JA, Anderson JH: Apparent increase in coronary heart disease with human proinsulin (HPI): randomization failure or HPI effect? (Abstract) Diabetologia 33 (Suppl. 1):A60, 1990
23. Wagenknecht LE, Mayer EJ, Rewers M, Haffner SM, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design and recruitment results. Ann Epidemiol 5:464-471, 1995
24. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study Am J Epidemiol 120:834-851, 1984
25. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC: Methods and prevalence of non-insulin dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311, 1989
26. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
27. Herbert V, Lau K, Gottlieb C, Bleicher S: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
28. Sobey WJ, Beer SF, Carrington CA, Clark PM, Frank BH, Gray IP, Luzio SD, Owens DR, Schneider AE, Siddle K, Temple RC, Hales CN: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulin. Biochem J 260:535-541, 1989
29. Ostrega D, Polonsky K, Nagi D, Yudkin J, Cox LJ, Clark PMS, Hales CN: Measurement of proinsulin and intermediates: validation of immunoassay methods by high-performance liquid chromatography. Diabetes 44:437-440, 1995
30. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86, 1985
31. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
32. Welch S, Gebhart SSP, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
33. Steil GM, Volund A, Kahn SE, Bergman RN: Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: suitability for use in population studies. Diabetes 42:250-256, 1993
34. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, Sands RE, Pei D, Savage PJ, Bergman RN: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
35. Bachorik PS, Albers JJ: Precipitation methods for quantification of lipoproteins. Methods in Enz 129:78-100, 1960
36. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
37. 1/2 year follow-up of the Helsinki Policeman Study population. Acta Med Scan 701 (Suppl. 1):38-52, 1985
38. Després JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
39. Howard G, O'Leary DH, Zaccaro D, Haffner SM, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
40. Bressler P, Bailey SR, Matsuda M, DeFronzo RA: Insulin resistance and coronary artery disease. Diabelologia 39:1345-1350, 1996
41. Shinozaki K, Hattori Y, Suzuki M, Hara Y, Kanazawa A, Takaki H, Tsushima M, Harano Y: Insulin resistance as an independent risk factor for carotid artery wall intima media thickening in vasospastic angina. Arterioscler Thromb Vasc Biol 17: 3302-3310, 1997
42. Lagrost L, Gambert P, Lallemant C: Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 14:1327-1336, 1994
43. Lahdenperä S, Syvänne M, Kahri J, Taskinen M-R: Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 39:453-461, 1996
44. Taskinen M-R: Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 6:153-160, 1995
45. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31:355-360, 1988
46. Huisman J, Oolbekkink M, Heine RJ, van der Veen EA, Erkelens DW: Effects of biosynthetic human proinsulin on serum lipids and glycaemic control in non-insulin-dependent diabetes mellitus. In Proinsulin: Pharmacokinetic and Clinical Aspects. van der Veen EA, Erkelens DW, Eds. Utrecht, Tessel Offset BV, 1989, p. 83-94
47. Røder ME, Porte D Jr, Schwartz RS, Kahn SE: Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 83:604-608, 1998
48. Byrne CD, Wareham NJ, Brown DC, Clark PMS, Cox LJ, Day NE, Palmer CR, Wang TWM, Williams DRR, Hales CN: Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 37: 889-896, 1994
49. Caixàs A, Ordóñez-Llanos J, de Leiva A, Payés A, Homs R, Pérez A: Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 46:1207-1213, 1997
50. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up. Diabetes 23: 105-111, 1974
51. Barrett-Connor E, Wingard DL: Sex difference in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 118:489-496, 1983